Cite
HARVARD Citation
Holmstroem, R. et al. (2022). COLAR: open-label clinical study of IL-6 blockade with tocilizumab for the treatment of immune checkpoint inhibitor-induced colitis and arthritis. Journal for immunotherapy of cancer. 10 (9), p. . [Online].